Yaichiro Okuzu1, Koji Goto2, Yutaka Kuroda2, Toshiyuki Kawai2, Shuichi Matsuda2. 1. Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. yokuzu@kuhp.kyoto-u.ac.jp. 2. Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Abstract
PURPOSE: This retrospective study aimed to evaluate the benefits of closed suction drainage (CSD) in hybrid total hip arthroplasty (THA) with intra-articular administration of tranexamic acid (TXA). METHODS: We included 369 hips that underwent primary hybrid THA between November 2015 and September 2020. We compared peri-operative blood test results, blood loss, and post-operative complications including transfusion, wound complications, and venous thromboembolism (VTE) with or without CSD. Propensity score matching was performed to balance baseline patient demographics. RESULTS: Transfusion, wound complications, and VTE were observed in 1.9% (seven), 2.4% (nine), and 2.2% (eight) of hips, respectively. There were no significant differences in transfusion, blood loss, wound complications, and deep venous thrombosis in both overall patients and propensity score-matched patients with or without CSD. The calculated total blood loss was approximately 600 ml and showed no significant difference between the two groups in the matched cohort (p = 0.59). CONCLUSION: CSD does not provide any benefits and is not needed in primary hybrid THA with intra-articular administration of TXA.
PURPOSE: This retrospective study aimed to evaluate the benefits of closed suction drainage (CSD) in hybrid total hip arthroplasty (THA) with intra-articular administration of tranexamic acid (TXA). METHODS: We included 369 hips that underwent primary hybrid THA between November 2015 and September 2020. We compared peri-operative blood test results, blood loss, and post-operative complications including transfusion, wound complications, and venous thromboembolism (VTE) with or without CSD. Propensity score matching was performed to balance baseline patient demographics. RESULTS: Transfusion, wound complications, and VTE were observed in 1.9% (seven), 2.4% (nine), and 2.2% (eight) of hips, respectively. There were no significant differences in transfusion, blood loss, wound complications, and deep venous thrombosis in both overall patients and propensity score-matched patients with or without CSD. The calculated total blood loss was approximately 600 ml and showed no significant difference between the two groups in the matched cohort (p = 0.59). CONCLUSION: CSD does not provide any benefits and is not needed in primary hybrid THA with intra-articular administration of TXA.
Authors: Yale A Fillingham; Dipak B Ramkumar; David S Jevsevar; Adolph J Yates; Stefano A Bini; Henry D Clarke; Emil Schemitsch; Rebecca L Johnson; Stavros G Memtsoudis; Siraj A Sayeed; Alexander P Sah; Craig J Della Valle Journal: J Arthroplasty Date: 2018-08-07 Impact factor: 4.757
Authors: Juan C Suarez; Colin A McNamara; Leticia C Barksdale; Cecilia Calvo; Caleb R Szubski; Preetesh D Patel Journal: J Arthroplasty Date: 2016-03-03 Impact factor: 4.757
Authors: Yale A Fillingham; Dipak B Ramkumar; David S Jevsevar; Adolph J Yates; Peter Shores; Kyle Mullen; Stefano A Bini; Henry D Clarke; Emil Schemitsch; Rebecca L Johnson; Stavros G Memtsoudis; Siraj A Sayeed; Alexander P Sah; Craig J Della Valle Journal: J Arthroplasty Date: 2018-06-27 Impact factor: 4.757